Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

26.03
-0.6900-2.58%
Post-market: 26.110.0800+0.31%18:31 EDT
Volume:272.07K
Turnover:7.14M
Market Cap:1.90B
PE:-110.46
High:27.14
Open:26.86
Low:26.01
Close:26.72
Loading ...
Jul 06, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Major Issues Report

8-K - Current report
Mar 03, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K - Current report